相关实验视频

Updated: Jul 12, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

胆固醇转移蛋白抑制作用的演变超出了心血管疾病

Nehal Mehta¹, Katerina Dangas², Marc Ditmarsch³

¹Mobius Scientific, Inc., JLABS @ Washington, DC, Washington, DC, USA.

Pharmacological research

|October 28, 2023

概括

胆固醇转移蛋白 (CETP) 的抑制主要降低了LDL胆固醇,影响心血管事件. 新出现的证据表明CETP和高密度脂蛋白 (HDL) 的作用延伸到阿尔茨海默病,糖尿病和败血症.

科学领域:

心血管科学心血管科学
代谢性疾病研究研究
神经退行性疾病研究神经退行性疾病研究

背景情况:

胆固醇转移蛋白 (CETP) 促进脂质在脂蛋白之间转移,特别是高密度脂蛋白 (HDL) 和低密度脂蛋白 (LDL).
CETP抑制已被研究为心血管事件的减少,最初与增加的HDL胆固醇有关.
最近的证据表明CETP抑制剂主要降低LDL胆固醇和阿波利波蛋白B,影响心血管结果.

研究的目的:

审查各种疾病中HDL和CETP抑制之间的生物学证据.
探索超出心血管疾病的CETP抑制的治疗潜力.
检查HDL和CETP在阿尔茨海默病,2型糖尿病,败血症和与年龄相关的黄斑变性 (AMD) 中的作用.

主要方法:

对生物证据和随机对照试验数据的文献综述.
关于高脂胆固醇和AMD风险的门德尔随机化研究的分析.
关于CETP抑制及其对脂质谱和疾病标志物的影响的综合发现.

主要成果:

目前已知CETP抑制对心血管的益处主要源于降低LDL胆固醇.
有证据表明,高密度胆固醇的功能 (胆固醇排放,抗炎性质) 在心血管疾病以外的疾病中至关重要.
CETP抑制剂试验没有显示过多的AMD风险,特定的HDL亚类可能有利于视网膜健康.

结论:

抑制CETP是一种有前途的治疗策略,对心血管疾病和其他疾病有影响.
了解HDL的多方面的作用是利用CETP抑制来治疗阿尔茨海默病,糖尿病和败血症的关键.
需要进一步研究HDL子类和CETP对AMD的影响.

关键词:

与年龄有关的黄斑变性.阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.胆固醇转移蛋白质的转移蛋白质糖尿病糖尿病糖尿病一个 Obicetrapib 的人.败血症这是一种败血症.

更多相关视频

Cholesterol Efflux Assay

Cholesterol Efflux Assay

Published on: March 6, 2012

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

相关概念视频

Cholesterol: Significance and Regulation

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Cholinesterases: Distribution and Function

Cholinesterases: Distribution and Function

Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...